Diminishing biofilm resistance to antimicrobial nanomaterials through electrolyte screening of electrostatic interactions by Harper, Robert
 
 
University of Birmingham
Diminishing biofilm resistance to antimicrobial
nanomaterials through electrolyte screening of
electrostatic interactions
Harper, Robert
DOI:
10.1016/j.colsurfb.2018.09.018
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Harper, R 2019, 'Diminishing biofilm resistance to antimicrobial nanomaterials through electrolyte screening of
electrostatic interactions', Colloids and Surfaces B: Biointerfaces, vol. 173, pp. 392-399.
https://doi.org/10.1016/j.colsurfb.2018.09.018
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Contents lists available at ScienceDirect
Colloids and Surfaces B: Biointerfaces
journal homepage: www.elsevier.com/locate/colsurfb
Diminishing bioﬁlm resistance to antimicrobial nanomaterials through
electrolyte screening of electrostatic interactions
Robert A. Harpera, Guy H. Carpenterb, Gordon B. Proctorb, Richard D. Harveyd,
Robert J. Gambogic, Anthony R. Geonnottic, Robert Hidera, Stuart A. Jonesa,⁎
a King’s College London, School of Cancer and Pharmaceutical Sciences, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK
b King’s College London Dental Institute, Division of Mucosal & Salivary Biology, Tower Wing, Great Maze Pond, London, SE1 9RT, UK
c Johnson and Johnson, Consumer & Personal Products Worldwide Division of Johnson & Johnson Consumer Companies, Inc, 199 Grandview Road, Skillman, NJ, 08558,
USA
dMartin-Luther-Universität Halle-Wittenberg, Institute of Pharmacy, Halle (Saale), Germany
A R T I C L E I N F O
Keywords:
(+) Alpha tocopheryl phosphate
Antimicrobial
Resistance
Tooth enamel
Nanomaterial
Oral bioﬁlm
Penetration
Electrolyte screening
Biological interactions
A B S T R A C T
The extracellular polymer substances (EPS) generated by bioﬁlms confers resistance to antimicrobial agents
through electrostatic and steric interactions that hinder molecular diﬀusion. This resistance mechanism is
particularly evident for antibacterial nanomaterials, which inherently diﬀuse more slowly compared to small
organic antibacterial agents. The aim of this study was to determine if a bioﬁlm’s resistance to antibacterial
nanomaterial diﬀusion could be diminished using electrolytes to screen the EPS’s electrostatic interactions.
Anionic (+) alpha-tocopherol phosphate (α-TP) liposomes were used as the antimicrobial nanomaterials in the
study. They self-assembled into 700 nm sized structures with a zeta potential of −20mV that were capable of
killing oral bacteria (S. oralis growth inhibition time of 3.34 ± 0.52 h). In a phosphate (-ve) buﬀer the -ve α-TP
liposomes did not penetrate multispecies oral bioﬁlms, but in a Tris (hydroxymethyl)aminomethane (+ve)
buﬀer they did (depth - 12.4 ± 3.6 μm). The Tris did not modify the surface charge of the α-TP nanomaterials,
rather it facilitated the α-TP-bioﬁlm interactions through electrolyte screening (Langmuir modelled surface
pressure increase of 2.7 ± 1.8mN/ m). This data indicated that EPS resistance was mediated through charge
repulsion and that this eﬀect could be diminished through the co-administration of cationic electrolytes.
1. Introduction
Bacterial bioﬁlms are structured communities that co-exist within
an extracellular matrix [1]. When a bioﬁlm is formed, the bacteria
within it become up to 1000 times more resistant to antimicrobial
treatment compared to the planktonic organisms [2]. This resistance
originates from the creation of subpopulations in the bioﬁlm [3], a
higher mutation rate [4], the upregulation of eﬄux pumps [5], mod-
iﬁcations in bacterial lipopolysaccharide (LPS) and a reduction in the
diﬀusion rates of antimicrobial agents in the bioﬁlm matrix, which ef-
fectively dilutes the administered agents. These characteristics render it
problematic to control bioﬁlm growth once they are established on the
surface of materials.
Nanomaterials can physically disrupt bioﬁlms, they can carry anti-
bacterial agents into bioﬁlm communities to control growth [6,7] and,
through modiﬁcation of their surface chemistry, their interactions with
the bioﬁlms can be controlled [8,9]. Therefore, it has been suggested
that nanomaterials can be designed to penetrate and kill bacteria in
bioﬁlm communities [10,11]. However, because each bioﬁlm can show
signiﬁcant variability with respect to the organisms and extracellular
components that it contains [12] and nanomaterial diﬀusion is in-
herently slower than small organic antimicrobials, designing a nano-
material that has the surface properties to allow it to eﬃciently diﬀuse
into a multispecies bioﬁlm after deposition onto a material surface is
not a trivial task [13–15]
One approach that could reduce the bioﬁlm resistance to nanoma-
terial diﬀusion is to co-administrator a penetration enhancer in order to
modify the bioﬁlm interactions with the nanomaterial surfaces. In a
similar manner to other biological barriers, e.g., epithelial mucus,
bacterial bioﬁlms restrict the diﬀusion of xenobiotics, within their
structured communities, through steric hindrance and electrostatic in-
teractions [16]. The electrostatic interactions in bioﬁlms arise from the
outer surface of the bacteria, which are generally negatively charged
due to their lipoteichoic acid and lipopolysaccharide components, and
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the extracellular polymer substances (EPS) [17], which can also be
negatively charged. Therefore, it seems feasible that cationic penetra-
tion enhancers could be useful to screen bioﬁlm electrostatic interac-
tions in attempt to dampen their capability to resist nanomaterial dif-
fusion.
Bioﬁlm electrostatic interactions with antimicrobial nanomaterials
could be screened using electrolytes because as electrolyte concentra-
tion increases in the bioﬁlm it would be expected that there would be a
reduction of the Debye length of the functional groups on the EPS [18].
For example, at an ionic strength of 0.1mM, the charge eﬀect, i.e.,
Debye length, should extend by approximately 10 nm, while at
100mM, it should only extend about 1 nm from the surface of the EPS.
This would increase the eﬀective pore size by about 10 nm as the ionic
strength is increased from 0.1 to 100mM, which could have a sig-
niﬁcant eﬀect on the diﬀusion of nanomaterials through oral bioﬁlms
[19]. Previous work has suggested that electrolyte screening interac-
tions do not inﬂuence the diﬀusion of small nanomaterials encountered
during environmental exposure, but there is emerging evidence that it
could be signiﬁcant for larger nanomaterials, i.e., those used to deliver
antimicrobial agents as they are typically larger than 10 nm [16,20].
Understanding the screening potential of electrolytes in bioﬁlms
could also provide valuable information about the properties of the
bioﬁlm EPS. Although it has been stated that the EPS is negatively
charged in bioﬁlms it is known that the EPS produced by diﬀerent
species of bacterial varies greatly in composition [21]. These variations
generate regions in the EPS that have a diﬀerent electrostatic charges
and diﬀerent steric interactions due to changes in the component’s
molecular weight (0.5–2.0× 106 Da) [22]. Studies have conﬁrmed that
EPS composition changes inﬂuence bioﬁlm interactions with lectins,
lipids and the surface of bacteria, but very little work has been per-
formed to understand how the EPS composition inﬂuences the access of
antimicrobial nanomaterials to the bacteria within the bioﬁlm [23].
One of the reasons is that when fully hydrated, the bulk properties of
bioﬁlms can be very similar to those of water, making it diﬃcult to
delineate the barrier between the bioﬁlm and the surrounding bulk li-
quid [24].
The aim of this study was to investigate if the resistance of bioﬁlms
to the penetration of antimicrobial nanomaterials could be overcome
through the co-administration of electrolytes that screen the bioﬁlms
electrostatic interactions with the result of enhancing the nanomater-
ial’s antimicrobial action. The mono alkyl phosphate amphiphile vi-
tamin (+) alpha-tocopherol phosphate (α-TP) was selected as the test
antimicrobial agent. Phosphate amphiphiles can form a range of dif-
ferent types of nanomaterials and they are arguably one of the most
ﬂexible types of anti-bioﬁlm systems. They can act directly to disrupt
bacterial bioﬁlms or they can be loaded with an antimicrobial agent,
which they can deliver into bioﬁlms [25,26]. α-TP was speciﬁcally
selected in this study as it has been shown to form bi-layer islands in
aqueous vehicles with a negative surface charge, thus if presented to a
bioﬁlm with a negatively charged EPS, electrolyte screening could po-
tentially increase the penetration of these nanomaterials into the bio-
ﬁlm [27]. The naturally occurring α-TP stereoisomer (RRR, + or d) was
employed in the study as it has been previously shown to have direct
antimicrobial activity, but as it was not easy to extract from natural
sources it synthesised from (+) alpha tocopherol (α-T) [18]. An oral
multispecies bioﬁlm was used in the study because previous work had
suggested that oral bioﬁlms display a net negative charge [19] and thus
they would restrict the diﬀusion of the α-TP into the bioﬁlm by elec-
trostatic repulsion. In addition, it was perceivable that the phosphate
nanomaterials and electrolytes could be co-localised for an extended
period of time in oral bioﬁlms in-vivo, thus the study results may be of
practical signiﬁcance in the ﬁeld of oral hygiene [28]. In-keeping with
the potential practical use of the study data the test agents were always
dissolved in a 20% ethanol 80% water vehicle at pH 7.4 as it mimicked
an oral healthcare product. The negatively charged phosphate, pre-
dicted to have very little eﬀect on the nanomaterial-bioﬁlm interaction,
and the positively charged Tris ((hydroxymethyl)aminomethane), pre-
dicted to screen the bioﬁlm-nanomaterial interactions through its three
ethyl alcohol groups, were used in the study as both these electrolytes
are known to be capable of adsorbing at biological interfaces [29]. As
the addition of the electrolytes to the bioﬁlm system also had the po-
tential to modify the antimicrobial nanomaterial size, surface polarity
and charge these characteristics were assessed using light scattering and
ﬂuorescence spectroscopy. Confocal microscopy was used to investigate
the multispecies salivary bioﬁlm penetration of the aggregates in the
presence of the two diﬀerent electrolytes [30]. These penetration re-
sults were investigated in more detail by studying the eﬀects of the
electrolytes on the interactions of the nanomaterials with artiﬁcial
Gram-positive bacteria membranes, using a Langmuir trough, and the
eﬀects of the electrolyte nanomaterial combinations on the bacteria
growth inhibition was assessed using a single species of oral bacteria,
Streptococcus oralis, a primary coloniser in the mouth [31].
2. Experimental section
2.1. Materials
(+) α-T (Type VI, natural extract ≥ 40% purity), phosphorus
oxychloride (POCl3) (≥99%), tetrahydrofuran (THF) (anhydrous)
(≥99.9%), trimethylamine (≥99%), triﬂuoroacetic acid (≥99%), Tris
hydrochloride (≥99%), cetylpyridinium chloride (CPC) (99.0–102%),
brain heart infusion (BHI) broth and glycerol were purchased from
Sigma Aldrich, UK. Absolute ethanol, propan-2-ol, hexane fractions
(60–80), disodium hydrogen phosphate, monosodium dihydrogen
phosphate, blood agar (BA) plates containing blood agar base no. 2 with
5% horse blood, 0.2 μM nylon syringe ﬁlters, hydrochloric acid and
sodium hydroxide were purchased from Fisher scientiﬁc Ltd, UK. De-
ionised water was used from laboratory supply. Hydroxyapatite discs
(5 mm diameter x 2mm thick) were purchased from Himed inc, USA.
Live/ dead ® BacLight™ bacterial viability kit, for microscopy, was
purchased from Life Technologies, UK. S. oralis NCTC 7864 T was
purchased from LGC standards, USA. 1-palmitoyl-2-oleoyl-sn-3-glycer-
ophospho-1-glycerol (POPG) and 1-palmitoyl-2-oleoyl-sn-3-glycer-
ophosphocholin (POPC) were purchased from Avanti polar lipids, USA.
Chromatographic paper, 10mm x 100m was purchased Whatman,
Maidstone, UK. Plastic syringes (1 and 20mL) were purchased from
Terumo, Philippines. Syringe needles were purchased from Macrolance,
Ireland. Disposable clear dynamic light scattering cuvettes (macro,
PMMA) and disposable folded capillary cells (DTS1070) where pur-
chased from VWR, Germany. Clear sterile polyester adhesive ﬁlms were
purchased from Starlab, UK.
2.2. Methods
2.2.1. (+) α-TP synthesis
(+) α-TP was synthesised as previously described to generate a
naturally derived, non-commercially available isoform [18]. In brief,
(+) α-T was phosphorylated in the presence of phosphorus oxychloride
with triethylamine in anhydrous THF for 3 h at room temperature. The
triethylamine hydrochloric acid salt was removed and the solution was
hydrolysed in water for 24 h. (+) α-TP was then extracted into hexane,
into water at basic pH and then again into hexane at acidic pH to re-
move the impurities. The product was puriﬁed by C18 chromatography
(ﬁnal purity 99%).
2.2.2. (+) α-TP aggregate characterisation
To understand the eﬀects of the electrolytes on the self-assembly of
(+) α-TP, ﬂuorescence emission spectra of (+) α-TP (195 μM) dis-
persions were recorded using a ﬂuorescence spectrometer ﬁtted with a
Xenon pulse lamp (Varian Cary Eclipse Fluorescence Spectrometer,
Agilent Technologies, UK). A ﬂuorescence cell (Helima ﬂuorescence cell
10mm, Helima UK Ltd., UK) with a 10mm path length was used.
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Excitation and emission slits were ﬁxed at 5 nm. In all measurements,
the excitation wavelength was set at 286 nm. The samples were scanned
from 250 to 450 nm at a wavelength scan rate of 120 nm/ min with a
PMT detector gain of 600 V. The experiments were performed at a
temperature of 25 °C. Fluorescence emission intensity increases/ de-
creases at 310 nm were monitored and normalised as shown in Eq. (1).
The normalised data points were then plotted against ion concentration
(Tris or phosphate). Analysis of the spectra was conducted using Ori-
ginPro software (OriginPro version 2016, OriginLab Corporation, US)
and the dose dependent analysis selected to assess trend patterns.
=
−
−
F F F
F F
X(%) 100n s min
max min (1)
Where Fn was the percentage normalised ﬂuorescence, Fs was the
sample ﬂuorescence, Fmin was the minimum ﬂuorescence and Fmax was
the maximum ﬂuorescence. The size of the aggregates (100 μM, n=3)
were analysed by photon correlation spectroscopy (Malvern Nanoseries
Zetasizer, Malvern Instruments Ltd, UK). Detection of the light scat-
tering signal was performed at 173° at 25 °C. The material refractive
index was set at 1.59, the material absorbance at 0.01, the dispersant
refractive index at 1.3469 and the sample viscosity (cP) at 2.143. Blank
solutions (containing just solvent) were used as a control. The same
instrument measured the zeta potentials using a dielectric constant of
78.5 and Smoluchowski (1.5) interpretation of the data with (+) α-T in
Tris buﬀer (25mM) as a control. The chemical stability of the (+) α-TP
was measured as described previously 18.
2.2.3. Bacterial model membrane interactions
A Langmuir trough (Nima technology equipment, Coventry, UK)
with a circular PFA trough (5 cm2, volume 20ml) on a stir plate
(Whatman stirrer, WC-303) with subphases of either a Tris or phos-
phate buﬀer (10mM, pH 7.4) were employed. The phospholipids used
to represent the lipid component of the bacterial plasma membrane
were anionic POPG and zwitterionic POPC as they have been previously
used in monolayer experiments as bacterial membrane mimics [32].
Although a large component of plasma membranes is made up of pro-
teins and indeed (+) α-TP has been found to be internalised via protein
channels [33], they were not included in this model as the anionic (+)
α-TP is likely to require an initial attraction through the cationic
components of the plasma membrane (lipidic and protein components),
i.e. cationic choline components, before internalisation in oral bacteria
and our aim was to assess how cationic and anionic buﬀer eﬀects ma-
nipulate this electrostatic attraction. To understand the eﬀects of the
electrolytes on the membrane architecture, POPC: POPG (3:1mg/ ml,
dissolved in chloroform) (lipid ratio was optimised in preliminary ex-
periments) lipids were deposited drop-wise at the air/ liquid interface
until their maximum surface pressures were achieved. To assess the
nanomaterial-membrane interactions, the lipids were again deposited
drop-wise at the air/ liquid interface until a 30mN/ m pressure was
reached in the Tris buﬀer subphase (as this is the pressure of a bacterial
membrane [34]) or the maximum pressure that could be achieved for
the phosphate buﬀer subphase (always> 30mN/m). The lipid mono-
layer was allowed to equilibrate over 30min at room temperature to
allow a stable surface pressure to be obtained (drift in surface pressure,
≤0.2mN/ m over 2min using Nima TR516 software). The α-TP sam-
ples (0.1 mL, 3mM, in 20% ethanol, 80% water, 150mM phosphate or
Tris at pH 7.4) were injected into the subphase with surface pressure
monitored over time at a constant surface area. Experiments were re-
peated in triplicate. Vehicle injections of 0.1 mL, 20% ethanol, 80%
water (150mM Tris, pH 7.4) were also conducted and any induced
pressure changes were recorded as controls.
2.2.4. S. oralis growth retardation
The assay was performed to assess if the electrolytes inﬂuenced (+)
α-TP’s antimicrobial activity in inhibiting streptococci bioﬁlm growth.
S. oralis NCTC 7864 T, stored in brain heart infusion (BHI) broth with
10% glycerol at −70 °C, was cultivated on blood agar (BA) plates
containing blood agar base no. 2 and 5% horse blood, at 37 °C under
aerobic conditions for S. oralis. Plates were subcultured every 48 h and
passaged no more than 6 times. Aliquots of BHI broth (20mL) were
inoculated with 3–4 colonies of bacteria from plates that had been
growing the bacteria for 24 h. After 18 h of growth 20 μl of bacteria
were then inoculated in a new BHI broth (20mL, 37 °C). When an op-
tical density reading between 0.2-0.3 (200 μL) was obtained at 620 nm
(ABS620) (i.e. the bacteria were in their exponential growth phase) the
bacterial cells were washed twice by centrifugation (1614 g, 10min,
25 °C) with sterile saline (20mL), and re-suspended in saline to provide
an ABS620 reading of 0.16 (UV–vis plate reader, iEMS Incubator/
Shaker, Thermo Scientiﬁc,UK). Aliquots (200 μL) of the cell suspension
were transferred to the wells of a sterile 96-well microtitre plate. The
plate was sealed and centrifuged for 60min at 2046 g. The supernatant
was removed by inverting the plate leaving an S. oralis bioﬁlm at the
base of each well. The wells were treated in triplicate with one of the
three α-TP aggregate formulations (200 μL) for 2min. The test solutions
were removed and the cells washed with saline (200 μL) twice. Aliquots
(200 μL) of BHI were added to the wells. The plates were sealed with
clear sterile polyester adhesive ﬁlms and incubated in aerobic condi-
tions at 37 °C in the UV–vis plate reader for 24 h, taking 620 nm ab-
sorbance readings every 15min. The Richards model (Eq. (2)) was used
to describe the growth curves [35].
= +
−
+ −
ABS ABS ABS ABS
exp μABS m t t[1 ( ( – )]t min
max min
i
m* * 1/ (2)
Where ABSt was the absorbance at time, ABSmin and ABSmax, re-
presented the asymptotic minimum and maximum absorbance’s, μABS
was the maximum speciﬁc growth rate, t was the time (h), ti was the
time to inﬂection (measure of lag time), or time to the point at which
the sign of the curve changes from a positive curvature to a negative
curvature or vice versa, and m was the modiﬁer for growth dampening.
The growth curve data were entered into the Originpro 2016 software
programme (OriginLab Corp., USA) and a nonlinear curve ﬁt was per-
formed on each growth curve to determine ti and ABSmax for each
treatment run. The ti value indicated the growth time to inﬂection
points and ABSmax measured the post-growth maximum population
densities. Each experiment was performed on three separate occasions.
2.2.5. Bioﬁlm penetration
The penetration assay investigation whether the electrolytes inﬂu-
enced (+) α-TP’s ability to penetrate into multispecies oral bioﬁlms.
One hydroxyapatite (HA) disc was added vertically to a micro cen-
trifuge tube containing UWMS (one donor, 400 μL) and incubated at
37 °C for 18 h. After their 18 h of incubation in unsterilised UWMS the
HA discs were removed, added to a fresh aliquot of sterilised heat-
treated (10min, 80 °C) UWMS (200 μL) incubated at 37 °C for 24 h,
removed, washed with saline (600 μL) and treated with Live/ dead
BacLight bacterial viability kits. Bioﬁlms were observed using 63x oil
immersion objective and a Leica sp2 confocal microscope with 488 and
568 nm excitation and 500–530 nm (green ﬂuorescence representing up
take of Syto 9 by live cells) and>620 nm (Red ﬂuorescence re-
presenting up take of propidium iodide by dead cells) emission ﬁlters.
Images were taken near the centre of the HA discs both sides. There was
no cross over between emission spectra and excitation intensities were
≤31%. The bioﬁlm growth was considered normal if they grew
30–60 μM. Bioﬁlm red / green ratios as a function of bioﬁlm depth were
measured using the z-stacking tool at 63x magniﬁcation taking an
image every ∼1 μm. The HA discs were then completely submerged in
one of the three diﬀerent α-TP aggregate test solutions (200 μL) in new
micro centrifuge tubes for 2min before being washed with saline
(600 μL). HA discs were then re-exposed to live/ dead staining for 1 h
and imaged again. Changes in the ratios of the red/ green staining as a
function of bioﬁlm depth demonstrated each of the three samples bio-
ﬁlm kill penetration. These studies were repeated in triplicate for each
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test solution. CPC was used as a positive control. Each HA disc was
imaged on both treated sides in two diﬀerent areas near the centre of
the discs. As a sterility control, sterile saliva was incubated with a
sterile HA disc and showed no bioﬁlm growth. In some cases, discs were
only imaged once, after bioﬁlm test sample exposure, to ensure kill was
caused by antimicrobial activity and not by the dual imaging and
staining process.
2.2.6. Statistical analysis
All data were expressed as their mean ± standard deviation (SD).
Statistical analysis of data was performed using Levine’s homogeneity
test to ensure that all sample group data was of acceptable distribution
(P > 0.05) before statistical signiﬁcance between the sample groups
was assessed by one way analysis of variance (ANOVA) tests with post-
hoc Tukey analysis in Origin 2016. Statistically signiﬁcant diﬀerences
were assumed when p≤ 0.05.
3. Results
3.1. (+) α-TP aggregate characterisation
The increase in the attenuated derived count rate compared to the
vehicles (149 ± 59.4 kcps, p < 0.05) conﬁrmed the (+) α-TP (100
μM) was forming aggregates in the 20% ethanol 80% solvent systems at
pH 7.4 utilised in this work. At low electrolyte concentrations
(< 1mM) increasing concentrations of Tris in the (+) α-TP vehicle
increased the ﬂuorescence emission intensity from the aggregates, the
converse was true when (+) α-TP was dispersed in a phosphate buﬀer
solution (See supplementary material, Fig. S1).
At electrolyte concentrations (between 1mM and 25mM) addition
of phosphate was not shown to have a signiﬁcant eﬀect on the (+) α-TP
aggregate size, but addition of Tris did reduce (+) α-TP size and size
distribution, although there was not a clear concentration dependant
eﬀect of Tris on aggregate size (Fig. 1A). The (+) α-TP aggregates in
the presence of Tris were found to consistently have a lower negative
zeta potential than when in the presence of phosphate (p < 0.05), but
this zeta potential did not change signiﬁcantly with increasing levels of
electrolytes. The phosphate electrolyte gave a concentration dependent
increase in negative surface aggregate charge (Fig. 1B). In light of the
fact that the size of aggregates have previously been shown to be in-
ﬂuential in the bioﬁlm penetration of phosphate amphiphile aggregates
27, the size and zeta potential data resulted in a ﬁxed (+) α-TP: elec-
trolyte ratio being used (1:187.5) in the subsequent bioﬁlm studies in
order to maintain a similar nanosized aggregate (p > 0.05) in the
presence of the two diﬀerent electrolytes such that electrostatic inter-
actions screening could be evaluated without major confounding ef-
fects. These were deﬁned as the test nanomaterials in this work.
3.2. Bacterial model membrane interactions
The POPC: POPG (3:1) phospholipids were capable of reaching a
maximum surface pressure of 38 ± 1.5mN / m when deposited on the
Tris buﬀer subphase, but they were only capable of reaching a max-
imum surface pressure of 15.2 ± 8.5mN / m when deposited on the
phosphate buﬀer subphase (Fig. 2A). This demonstrated that the ca-
tionic Tris and anionic phosphate buﬀers interacted with the ionic
phospholipids and modiﬁed the monolayer architecture with Tris al-
lowing more eﬀective membrane packing compared to the phosphate
electrolytes.
When the (+) α-TP nanomaterials were co-administered with Tris
to the Langmuir subphase, the monolayer equilibration pressure (set at
30mN/ m to replicate the pressure of bacterial membranes) was found
to immediately increase by 2.7 ± 1.8 (P > 0.05) showing a favour-
able interaction of (+) α-TP with the monolayer (Fig. 2B). When (+)
the α-TP was co-administered with phosphate into the Langmuir sub-
phase, there was no increase in monolayer pressure indicating a neg-
ligible interaction of (+) α-TP with the monolayer. The vehicle alone
was found to slightly reduce the surface pressure over time (1mN/ m
over 5min), presumably due to the ethanol-induced phase transition
eﬀect of ethanol on the POPC: POPG monolayer in the application ve-
hicle, but this was not thought to be consequential in the experiments
reported herein (See supplementary data, Fig. S2) [36].
3.3. S. oralis bioﬁlm growth inhibition
The (+) α-TP nanomaterials co-administered with Tris displayed a
signiﬁcant retardation of bacteria growth (inﬂection point
3.34 ± 0.52 h) compared to a Tris vehicle alone (1.69 ± 0.17 h,
p=0.0001) (Fig. 3A). The (+) α-TP nanomaterials co-administered
with phosphate electrolytes had no signiﬁcant eﬀect on bacterial
growth (2.01 ± 0.30 h, vs vehicle of 1.81 ± 0.15, p > 0.05). Inter-
estingly both the (+) α-TP systems reduced the post-growth maximum
Fig. 1. Eﬀect of buﬀer on +) α-tocopheryl phosphate aggregate architecture. Comparison of (+) α-tocopheryl phosphate (0.1 mM) aggregate size (A) and zeta
potential (B) when formulated with increasing concentrations of Tris or phosphate at pH 7.4 in 20% ethanol 80% water vehicles. Data represents mean ± SD, n= 3.
Aggregate: ion ratio of 1:187.5 is highlighted by a box.
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population density of S. oralis (p < 0.05 compared with vehicle con-
trols) (Fig. 3B). Thus, it appeared that the Tris facilitated decreased
growth eﬀect on S. oralis (since time to inﬂection point was increased)
whereas the phosphate caused increased death rate shown in the
maximum population density, i.e., when the growth rate equals the
death rate.
3.4. UWMS bioﬁlm kill penetration
The confocal images of (+) α-TP nanomaterials co-administered
with Tris (-18.9 ± 2.6mV zeta potential, 718 ± 471 nm diameter)
showed an eﬀective kill of the bacteria at a bioﬁlm depth of 4.2 um, but
they did not kill at 15 microns (see Supplementary material, Fig. S4).
The Tris vehicle alone was found not to kill any bacteria in the salivary
bioﬁlms (see Supplementary material, Fig. S5). The bioﬁlm kill pene-
tration depths were considered to be at the points where post (+) α-TP
application live/ dead staining ratios matched that of the pre (+) α-TP
application live/ dead staining ratios, i.e., there was no longer any sign
of bacterial killing (see supplementary material, Fig. S3). The bacter-
icidal penetration depth of the (+) α-TP nanomaterials dispersed in
Tris was calculated as 12.4 ± 3.6 um. CPC, which acted as a positive
control, killed bacteria in the bioﬁlm to a depth of 16.1 ± 4.3 microns.
The (+) α-TP co-administered with phosphate (-29.6 ± 2.4mV zeta
potential, 392 ± 6 nm diameter) was not capable of killing bacteria in
the bioﬁlms (Fig. 4).
4. Discussion
The phosphorylation of (+) α-T generated (+) α-TP, which dis-
played a negatively charged phosphate head group at physiological pH.
The dynamic light scattering data for (+) α-TP conﬁrmed that it
formed aggregates at the nanoscale in a polar disperse phase that mi-
micked a mouthwash solution. The type of aggregates that (+) α-TP
formed in the presence of Tris have previously been reported to be
planar bilayer islands 18. Attempts in this work to characterise the ag-
gregate type in the phosphate buﬀer failed because, unlike the Tris
system, the precipitation of the phosphate salt upon sample preparation
made it impossible to obtain reliable atomic force microscopy images.
However, the ﬂuorescence and light scattering measurements did pro-
vide information on the eﬀects of the Tris and phosphate electrolytes on
the properties of the (+) α-TP aggregates. The increase in ﬂuorescence
intensity upon the titration of low concentrations of Tris into the dis-
perse phase of the (+) α-TP suggested that aggregate surface potential
decreased upon the addition of Tris [37] and this translated into a lower
zeta potential of the aggregates in Tris compared to the phosphate
buﬀer. Increasing the concentration of Tris in the (+) α-TP system also
reduced the size and size distribution of the (+) α-TP aggregates.
However, at higher Tris concentrations no concentration dependent
eﬀects on aggregate zeta potential were observed. This data suggested
Fig. 2. Eﬀect of electrolytes on bacterial
monolayer (POPC: POPG (3:1)) architecture
and nanomaterial interaction. (A) Maximum
constant area monolayer surface pressure
achieved using a Tris (T) or phosphate (P)
subphase (B) Monolayer surface pressure
change due to (+) alpha tocopheryl phosphate
nanomaterial injection into the subphase.
Fig. 3. Eﬀect of electrolytes Tris (T) and phosphate (P) on (+) alpha tocopheryl
phosphate nanomaterials (A) inhibition of Streptococcus oralis growth and (B)
inhibition ofStreptococcus oralis population density. Data shows mean ±
standard deviation, n=3.
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that Tris inﬂuenced the corona surrounding the phosphate amphiphile
polar head group to decrease the water organisation at the membrane
interface and supress the surface charge [34], but it was not capable of
neutralising the molecular charge and hence the Tris interactions were
not thought to be very strong. Likewise the phosphate showed, through
both the ﬂuorescence and zeta potential measurements that the elec-
trolyte was associating to some degree with the (+) α-TP aggregates
and enhancing their negative charge. The strengthening of the ag-
gregate surface charge could have been a consequence of the negative
inorganic phosphate groups (HPO42−/ H2PO-) associating with the (+)
α-TP aggregates surfaces (R-OPO3H-/ R-OPO32−) through hydrogen
bonding, hence its greater eﬀect on aggregate zeta potential compared
to the Tris. It is known that electrolytes such as Tris, carbonate, caco-
dylate, phosphate and citrate do not only set the bulk solvent pH, they
also adsorb to the interfaces to aﬀect the nanostructure dispersion and
electrophoretic mobility [38]. It appeared in this study that, for phos-
phate this resulted in surface charge ampliﬁcation as a result of ad-
sorption of like-charged ions (co ions) onto the charged aggregate
surfaces [39], whilst for Tris aggregate absorption resulted in a mild
suppression of the zeta potential. The characterisation of the (+) α-TP
aggregates in the two electrolyte solutions allowed the selection of two
materials with a similar size, identical electrolyte concentration, but
diﬀerent surface charges to use in the subsequent bioﬁlm experiments.
The Langmuir experiments showed that the electrolytes, in the ab-
sence of the (+) α-TP nanomaterials, had an eﬀect on the monolayer in
a similar manner to previously published studies [40,41]. POPC is a
zwitterion, whilst POPG is anionic hence together the POPC: POPG
(3:1) monolayers display a net negative charge, resulting in electro-
static attraction between cations such as Tris with the anionic POPG
head groups. This ion-pairing can swell the phospholipid supramole-
cular structures and create ‘gaps’ in the monolayer, which are ﬁlled by
additional phospholipids that increase the surface pressure compared to
the monolayer formed without the cationic electrolytes [42]. The
phosphate electrolytes also interacted with the deposited POPC: POPG
phospholipids, probably through ion-pairing with choline and hy-
drogen bonding with the organic phosphate groups in a similar way to
the interactions observed on the (+) α-TP nanomaterial surfaces (en-
hanced negative zeta potential) [43,44], The increase in monolayer
electronegativity with the phosphate electrolytes was observed as they
were less eﬀective in encouraging additional phosphates to pack into
the monolayer and hence it achieved a lower surface pressure compared
to the Tris system [45–51].
Setting the equilibration pressure of the model bacterial monolayer
to 30mN/ m (equivalent to that of bacteria) and monitoring the pres-
sure change in response to the injection of (+) α-TP nanomaterials into
both the Tris and phosphate subphases assessed the inﬂuence of the
electrolytes on the (+) α-TP nanomaterial interactions with the
monolayer. In the presence of Tris the nanomaterials showed rapid
interaction with the monolayer, but in the presence of phosphate there
were no interactions between the (+) α-TP nanomaterials and the
membrane. These results suggested that the Tris interacted with the
membrane to facilitate the nanomaterial membrane interactions whilst
phosphate reduced both aggregate and monolayer surface charges,
causing an anionic electrostatic repulsive barrier between the aggregate
and the monolayer. There is evidence in the literature that large organic
monovalent cations, like Tris, can interact with bacterial membranes to
make them more permeable [45–51] This is thought to be because the
ion-pairing can disrupt the phospholipid packing and this can ‘sensitise’
the membranes to the eﬀects of antimicrobials. This ‘sensitisation’ can
be beneﬁcial in a number of scenarios, for example, Tris has previously
been shown to increase the permeability of both nitroceﬁn and the
enzyme lysozyme in the Pseudomonas aeruginosa outer membrane [52]
and it has also been shown to facilitate stronger interactions of the
antibiotic tetracycline with monolayer phospholipids [53].
The magnitude of the POPC: POPG monolayer pressure increase
(2.7 mN/ m) when the (+) α-TP nanomaterials were injected into the
Tris subphase suggested that the (+) α-TP was inserting into the
monolayer rather than rupturing it [54,55]. This (+) α-TP nanoma-
terial insertion into the bacterial membrane may account for altered
growth of S. oralis when compared to (+) α-TP in the presence of
phosphate. Although the phosphate buﬀer was shown to interact with
bacterial membranes, that lack of surface pressure increase when (+)
α-TP was injected in the presence of the phosphate suggested that it did
not alter the membrane permeability [56]. The action of Tris to im-
prove the (+) α-TP interactions with bacterial membranes could im-
prove the bacterial intracellular levels of (+) α-TP. Although (+) α-TP
is endogenous in some cells, its intercellular concentrations appears to
be highly regulated and increasing its concentration in the cells could
be an eﬀective means to trigger cell death as it is a potent signalling
molecule that targets enzymes including acid/ alkaline phosphatases,
adenosinetriphosphatas, diphosphopyridine nucleotidase and mRNAs
encoding enzymes [54,57]. The diﬀerential eﬀects of the (+) α-TP with
phosphate and Tris in bacterial growth assays supported the hypothesis
that (+) α-TP was more readily taken up by the cells in the presence of
Tris. When accompanied by phosphate the bacterial growth assays
showed that (+) α-TP has to wait for cell division in order to induce an
eﬀect, but in Tris (+) α-TP penetrated the cell to cause an eﬀect im-
mediately upon application.
Using Tris but not phosphate in the dispersion medium allowed the
700 nm (+) α-TP nanomaterials to penetrate the salivary bioﬁlms to
kill the bacteria in multispecies bacterial communities to greater
depths. This data, in light of the aggregate characterisation, Langmuir
and planktonic bioﬁlm studies, suggested that the EPS of the oral
multispecies bioﬁlm was predominantly negatively charged and this
charge was being screened by the positively charged Tris. The EPS has
previously been shown to inhibit the diﬀusion of both positively [58]
and negatively [47] charged small organic antimicrobials through
electrostatic interaction, but this current work also showed the im-
portance of these electrostatic interactions for comparatively large,
700 nm, nanomaterials.
Fig. 4. Eﬀect of electrolytes on unsterilized whole mouth saliva bioﬁlm kill
penetrationdepths of (+) alpha tocopheryl phosphate nanomaterials. Top, live/
dead stain confocal microscopy images at 4.2 μm depths. Bottom. Bioﬁlm pe-
netration depths of (+) alpha tocopheryl phosphate nanomaterials with Tris (T)
and phosphate (P) compared with cetylpyridinium chloride (CPC) in Tris as a
positive control. N= 3 results bars show mean ± standard deviation.
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5. Conclusions
The co-administration of anionic (+) α-TP nanomaterials with the
cationic electrolyte, Tris, enhanced their penetration into bioﬁlms and
their interactions with the bacteria. This appeared to occur not by di-
minishing the (+) α-TP nanomaterials negative surface charge, but
through diminishing their electrostatic interactions with the bioﬁlms
and the bacterial membranes. These changes facilitated the nanoma-
terial bioﬁlm penetration and enabled the bacteria at the heart of the
bioﬁlm communities to be killed. Similar eﬀects could not be achieved
by the co-administration of the (+) α-TP nanomaterials with the
phosphate electrolytes, which provided evidence that it was the
screening of negative electrostatic interactions using Tris which pro-
duced the beneﬁcial eﬀects. In oral health the tooth surface is an at-
tractive adsorptive site for negatively charged nanomaterials and in our
previous work we have found (+) α-TP binds to hydroxyapatite 18.
Hence, the co-administration of Tris with the (+) α-TP nanomaterials
to allow penetration to the tooth surface where (+) α-TP could adsorb
to the enamel would provide a considerable substantive antimicrobial
action.
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